Brief: Fibrogen Announces Sale Of Fibrogen China To Astrazeneca For About $160 Million
Feb 20 (Reuters) - FibroGen Inc FGEN.O :
* FIBROGEN ANNOUNCES THE SALE OF FIBROGEN CHINA TO
ASTRAZENECA
FOR APPROXIMATELY $160 MILLION
* FIBROGEN INC - ANNOUNCES SALE OF CHINA SUBSIDIARY TO
ASTRAZENECA
FOR $160 MILLION
* FIBROGEN INC - CASH RUNWAY EXTENDED INTO 2027
Source text: ID:nGNXtnJ8x
Further company coverage: FGEN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyntra Bio
See all newsBrief: Kyntra Bio Appoints Andrew E. Singer, Mba To Its Board Of Directors
NASDAQ RESUMED AT 01:28 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:23 PM
Kyntra Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kyntra Bio swings to profit in Q2 on deconsolidation of subsidiary